INIS
drugs
100%
reviews
100%
risks
80%
management
40%
dimensions
40%
patients
20%
information
20%
tools
20%
cost
20%
optimization
20%
assessments
20%
regression analysis
20%
interventions
20%
multivariate analysis
20%
interactions
20%
public health
20%
Medicine and Dentistry
Patient Care
100%
Systematic Review
100%
Drug Therapy
100%
Observational Study
100%
Polypharmacy
100%
Combination Drug
10%
Potentially Inappropriate Medication
10%
Health Care Cost
5%
Cross Sectional Study
5%
Public Health
5%
Drug Use
5%
Health System
5%
Adverse Drug Reaction
5%
Drug Interaction
5%
Intoxication
5%
Keyphrases
Continuity of Care
100%
Polypharmacy
100%
Medication Appropriateness
100%
Risk of Bias
15%
CARE Measure
15%
Drug Combination
10%
Potentially Inappropriate Medication
10%
Objective Standard
10%
High Risk
5%
Adverse Health Effects
5%
Risk Factors
5%
Public Health Risk
5%
High-quality Care
5%
Systematic Literature Review
5%
Regression Analysis
5%
PubMed
5%
Methodological Quality
5%
Embase
5%
Low Risk
5%
CINAHL
5%
Health Systems
5%
Subjective Measures
5%
Drug Use
5%
Observational Cohort
5%
Quality Assessment Tool
5%
Patient-centered Outcomes
5%
Drug Interactions
5%
Adverse Drug Events
5%
Design Futures
5%
Management Continuity
5%
Informational Continuity
5%
Relational Continuity
5%
Management Dimensions
5%
Potentially Inappropriate Drugs
5%
Avoidable Costs
5%
Duplicate Medication
5%
Intervention Targets
5%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Polypharmacy
100%
Combination Drug
18%
Toxic Injury
9%
Cross-Sectional Study
9%
Adverse Drug Reaction
9%
Drug-Drug Interaction
9%